Effectiveness of a community-based intervention for weight loss on cardiometabolic risk factors among overweight and obese women in a low socio-economic urban community: findings of the MyBFF@home

Liyana, Ahmad Zamri; Appannah, Geeta; Sham, Siti Yazmin Zahari; Fazliana, Mansor; Nor, Noor Safiza Mohamad; Ambak, Rashidah; Samad, Azah Abdul; Dahlan, Nofi Yuliani; Aris, Tahir

doi:10.1186/s12905-018-0593-1

Table 3 Within- and between-group comparisons of cardiometabolic risk factors during weight-loss intervention phase

From: Effectiveness of a community-based intervention for weight loss on cardiometabolic risk factors among overweight and obese women in a low socio-economic urban community: findings of the MyBFF@home

Outcome measures	Group	Baseline Mean (SD)	6 month Mean (SD)	Change within-group	p-value^a	Mean Difference of change Between group	p-value^b
Outcome measures	Group	Baseline Mean (SD)	6 month Mean (SD)	MD (95% CI)	p-value^a	MD (95% CI)	p-value^b
FPG (mmol/L)	Control (n=114)	5.64 (1.03)	5.58 (1.28)	-0.05 (-0.25, 0.14)	0.569	0.06 (-0.23, 0.34)	0.692
FPG (mmol/L)	Intervention (n=129)	5.63 (1.45)	5.51 (0.96)	-0.11 (-0.32, 0.10)	0.287	0.06 (-0.23, 0.34)	0.692
Triglycerides (mmol/L)	Control (n=114)	1.35 (0.66)	1.44 (0.72)	0.09 (-0.04, 0.22)	0.193	-0.01 (-0.20, 0.18)	0.906
Triglycerides (mmol/L)	Intervention (n=129)	1.35 (0.67)	1.45 (0.63)	0.10 (-0.04, 0.23)	0.155	-0.01 (-0.20, 0.18)	0.906
Total cholesterol (mmol/L)	Control (n=114)	5.70 (1.09)	5.43 (0.97)	-0.27 (-0.42, -0.11)	0.001**	-0.06 (-0.28, 0.17)	0.620
Total cholesterol (mmol/L)	Intervention (n=129)	5.59 (1.02)	5.38 (0.85)	-0.21 (-0.38, -0.05)	0.012*	-0.06 (-0.28, 0.17)	0.620
HDL-C (mmol/L)	Control (n=114)	1.38 (0.23)	1.33 (0.23)	-0.05 (-0.10, -0.01)	0.011*	-0.05 (-0.11, 0.01)	0.103
HDL-C (mmol/L)	Intervention (n=129)	1.31 (0.23)	1.31 (0.25)	0.00 (-0.05, 0.04)	0.811	-0.05 (-0.11, 0.01)	0.103
LDL-C (mmol/L)	Control (n=114)	4.59 (1.32)	4.45 (1.09)	-0.14 (-0.37, 0.09)	0.223	-0.09 (-0.38, 0.19)	0.526
LDL-C (mmol/L)	Intervention (n=129)	4.44 (1.11)	4.39 (0.94)	-0.05 (-0.23, 0.13)	0.585	-0.09 (-0.38, 0.19)	0.526
LDL-C/HDL-C ratio	Control (n=114)	3.35 (0.91)	3.43 (0.91)	0.07 (-0.12, 0.25)	0.486	0.04 (-0.12, 0.28)	0.741
LDL-C/HDL-C ratio	Intervention (n=129)	3.43 (0.86)	3.43 (0.94)	0.03 (-0.13, 0.18)	0.748	0.04 (-0.12, 0.28)	0.741
TC/HDL-C ratio	Control (n=114)	4.15 (0.71)	4.18 (0.79)	-0.02 (-0.14, 0.11)	0.82	0.05 (-0.17, 0.27)	0.642
TC/HDL-C ratio	Intervention (n=129)	4.30 (0.70)	4.25 (0.88)	-0.07 (-0.24, 0.10)	0.432	0.05 (-0.17, 0.27)	0.642

Notes: Boldface indicates statistically significance *p<0.05, **p<0.01
Mean differences within group and between group are in mean (95% CI), a negative change indicates a fall in average from baseline to 6 month
^aPaired t- test (between baseline and 6-month measurement), significant at p<0.05
^bIndependent t-test, significant at p<0.05
Abbreviations: SD standard deviation, MD mean difference, FPG fasting plasma glucose, LDL-C Low-density lipoprotein-cholesterol, HDL-C High-density lipoprotein-cholesterol

Back to article page

ISSN: 1472-6874

Contact us

Submission enquiries: bmcwomenshealth@biomedcentral.com
General enquiries: ORSupport@springernature.com

BMC Women's Health

Contact us